Ask ten people what a peptide is and you may get ten different answers, most of them borrowed from a supplement ad. The word has been attached to everything from face cream to protein powder, and that marketing haze makes it harder to have a useful conversation about the medications that actually have research behind them.
Peptides for weight loss are a real and well-studied category, but the label covers a wide range. Some compounds have been through large randomized trials and carry FDA approval. Others have almost no human data at all. Knowing which is which may be the difference between a treatment plan and an expensive guess.
What is a peptide, and how does it affect weight?
A peptide is a short chain of amino acids, smaller than a protein, that your body uses to send signals between cells. Insulin is a peptide. So is the hormone that tells your brain you have eaten enough.
The weight loss medications getting attention right now are mostly GLP-1 receptor agonists. They mimic glucagon-like peptide-1, a hormone your gut releases after a meal. That signal can slow how quickly your stomach empties, reduce appetite, and increase the feeling of fullness.
Semaglutide works this way. Tirzepatide acts on two receptors, GLP-1 and GIP, which appears to produce a somewhat stronger effect in the trials conducted so far.
The mechanism explains why patients often describe the experience as food noise quieting down. The constant background thinking about the next meal may fade, and portions that used to feel normal can start to feel like too much.
What does the research actually show?
The published trial data on GLP-1 medications is substantial, which sets them apart from most things marketed for weight loss.
In the STEP 1 trial, adults taking weekly semaglutide alongside lifestyle changes lost an average of roughly 15 percent of body weight over 68 weeks, compared with about 2.4 percent in the placebo group. The SURMOUNT-1 trial of tirzepatide reported average reductions in the range of 15 to 21 percent depending on dose across 72 weeks.
Those are averages, and averages hide a lot. Some participants lost considerably more. Some lost very little. Individual response varies, and no honest provider can tell you in advance which group you will fall into.
Research has also looked at what happens after stopping. The STEP 4 extension found that participants who discontinued semaglutide regained a substantial portion of the weight over the following year. That finding shapes how these medications should be understood: as ongoing treatment for a chronic condition rather than a short course that fixes something permanently.
Cardiovascular data has been encouraging as well, with the SELECT trial reporting reduced risk of major cardiovascular events in patients with existing heart disease and overweight or obesity.
Are compounded peptides the same as approved medications?
Compounded versions are not the same product, and the distinction matters more than the price difference suggests.
FDA-approved medications go through review for safety, effectiveness, manufacturing consistency, and labeling. Compounded preparations are made by pharmacies for individual patients and do not go through that approval process. The FDA has issued warnings about adverse events linked to compounded semaglutide, including dosing errors when patients drew up doses themselves from vials.
Some compounded products have also used salt forms of semaglutide that differ from the active ingredient in approved medications, and those forms have not been evaluated for safety or effectiveness.
There are legitimate reasons a physician may consider compounded options in specific situations. That decision should be made with a licensed provider who knows the sourcing, not driven by an online ad promising the same results for a fraction of the cost.
Then there is the category with almost no human evidence behind it. Compounds sold online as growth hormone secretagogues or fat-loss peptides are frequently marketed with research the seller never conducted and results no trial supports. Products labeled for research use only are not approved for human use at all.
Who might be a candidate for peptide-based treatment?
Clinical guidelines generally consider these medications for adults with a BMI of 30 or higher, or 27 and above with a weight-related condition such as type 2 diabetes, high blood pressure, or sleep apnea.
BMI is a starting point rather than a verdict. A full evaluation should look at your medical history, current medications, thyroid function, and metabolic labs before anything is prescribed.
Certain histories may make these medications inappropriate, including a personal or family history of medullary thyroid carcinoma or MEN 2. Pancreatitis history, gallbladder disease, severe gastrointestinal conditions, and pregnancy all require careful discussion.
Side effects are common, particularly early on. Nausea, constipation, diarrhea, and reflux affect a meaningful share of patients, and they tend to be worst after dose increases. Most improve with time and slower titration. Some patients cannot tolerate the medication at all.
What should a supervised program include?
A responsible medical weight loss program treats the medication as one component rather than the whole plan.
Reasonable elements include:
- Baseline lab work and a full medical history before starting
- Gradual dose escalation rather than jumping to a target dose
- Regular follow-up to monitor tolerance and adjust
- Attention to protein intake and resistance training, since rapid weight loss can include lean mass
- A conversation about what happens long term, before you start rather than after
That last point gets skipped constantly. These medications may work well while you take them, and the research suggests weight tends to return when they stop. Planning for that from day one is part of doing this properly.
At SC My Care, Dr. Cooper supervises medical weight loss for patients across Lexington, Columbia, and the Midlands, with the labs, monitoring, and follow-up handled inside the same practice that manages the rest of your care.
This article is for general information and is not medical advice. Individual results vary. Talk with a licensed physician about whether any treatment may be appropriate for your situation.
If you want a medical opinion on whether these medications could fit your health picture, start a conversation with SC My Care about medical weight loss.